Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
12/05/2000 | US6156907 Process for preparing 1-substituted 4-cyano-1,2,3-triazoles |
12/05/2000 | US6156781 Antiinflammatory agents for skin |
12/05/2000 | US6156779 Fungicides against candida |
12/05/2000 | US6156758 Antibacterial quinazoline compounds |
12/05/2000 | US6156739 Quinazolinone compounds |
12/05/2000 | US6156136 N,N'-azobis-nitroazoles and analogs thereof as igniter compounds for use in energetic compositions |
11/30/2000 | WO2000071572A1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
11/30/2000 | WO2000071537A1 New pharmaceutically active compounds |
11/30/2000 | WO2000071536A1 Heteroaryloxypyrimidine insecticides and acaricides |
11/30/2000 | WO2000071535A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE |
11/30/2000 | WO2000071524A1 2-nh-pyridones and pyrimidones as mrs inhibitors |
11/30/2000 | WO2000071522A1 Benzimidazole derivatives and their use as methionyl t-rna synthetase inhibitors |
11/30/2000 | WO2000071516A2 INHIBITORS OF FACTOR Xa |
11/30/2000 | WO2000071515A2 INHIBITORS OF FACTOR Xa |
11/30/2000 | WO2000046199A3 Indole derivatives as anti-inflammation agents |
11/30/2000 | DE19924818A1 Substituierte Phenylcyclohexancarbonsäureamide Substituted Phenylcyclohexancarbonsäureamide |
11/30/2000 | CA2374788A1 Inhibitors of factor xa |
11/30/2000 | CA2372743A1 New pharmaceutically active compounds |
11/30/2000 | CA2372567A1 Indole-type derivatives as inhibitors of p38 kinase |
11/30/2000 | CA2371904A1 Inhibitors of factor xa |
11/29/2000 | EP1054960A1 Heteroaromatic oligoamides as affinity ligands |
11/29/2000 | EP1054871A2 Pyrimidines and triazines as integrin antagonists |
11/29/2000 | EP1054865A1 Farnesyl transferase inhibitors |
11/29/2000 | CN1275124A Phthalazine derivatives and remedies for erectile dysfunction |
11/29/2000 | CN1275123A Prostaglandin agonists and their use to treat bone disorders |
11/29/2000 | CN1274734A Orange and deep red mixture of reactive dyes |
11/29/2000 | CN1274718A Novel benzo-[3,4] cyclobutano [1,2-C] pyrroles compound, its prepn. and medicine composition containing the same |
11/29/2000 | CN1058966C Producing process for crystal of z-oxyethyl -1-[2'-(1H-tetrazole-5-radical) diphenyl-4-(methyl) benzimidazole-7-hydroxy acid 1-(cyclohexyloxy) |
11/28/2000 | US6153672 Hydroxyfunctional or aminofunctional material as a resin. thick films with no pinholes are prepared from the curable compositions using powder coating techniques. |
11/28/2000 | US6153642 Useful as antineoplastic and antiviral agents |
11/28/2000 | US6153641 Pharmaceutically active compounds |
11/28/2000 | US6153640 For treating depression, panic attacks, obsessive-compulsive disorders, phobias, impulsive disorders, drug abuse or anxiety |
11/28/2000 | US6153634 4,5-azolo-oxindoles |
11/28/2000 | US6153622 Estrogen agonists/antagonists |
11/28/2000 | US6153617 Used for reating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis |
11/28/2000 | US6153613 2,3-diketopiperazine derivatives or their salts |
11/28/2000 | US6153611 As non-dopaminergic antiischemic compounds for treating brain disorders |
11/28/2000 | US6153369 Photographic element containing pyrazolone pug releasing coupler and imaging process employing same |
11/28/2000 | CA2173788C Substituted thiophene derivative and agricultural and horticultural fungicide containing the same as active ingredient |
11/23/2000 | WO2000069849A1 Pyrazole carboxamides useful for the treatment of obesity and other disorders |
11/23/2000 | WO2000069848A1 Compounds having cytokine inhibitory activity |
11/23/2000 | WO2000069847A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
11/23/2000 | WO2000069836A1 Short-acting benzodiazepines |
11/23/2000 | WO2000069834A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
11/23/2000 | WO2000069810A1 Glucagon antagonists/inverse agonists |
11/23/2000 | WO2000069424A2 Method of treating psychotic disorders |
11/23/2000 | WO2000035920A3 4,5-azolo-oxindoles |
11/23/2000 | DE19922826A1 Orange- und scharlachfarbige Mischungen von Reaktivfarbstoffen Orange and scarlet colored mixtures of reactive dyes |
11/23/2000 | CA2374559A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
11/23/2000 | CA2373892A1 Glucagon antagonists/inverse agonists |
11/23/2000 | CA2373855A1 Method of treating psychotic disorders |
11/23/2000 | CA2373510A1 Pyrazole carboxamides useful for the treatment of obesity and other disorders |
11/23/2000 | CA2372617A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
11/23/2000 | CA2372494A1 Compounds having cytokine inhibitory activity |
11/22/2000 | EP1054043A2 Orange and scarlet coloured mixtures of reactive dyes |
11/22/2000 | EP1054005A1 Sulfonamide derivatives, process for producing the same and utilization thereof |
11/22/2000 | EP1054004A1 Novel pyrimidine-5-carboxamide derivatives |
11/22/2000 | EP1054003A1 Urocanic acid derivatives |
11/22/2000 | EP1053230A1 Triazine antiviral compounds |
11/22/2000 | EP1053224A1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
11/22/2000 | EP0663823B1 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
11/22/2000 | CN1274285A Alpha-ketoamide multicatalytic protease inhibitors |
11/22/2000 | CN1058710C Benzamide derivatives, process for prepn. thereof and pharmaceutical compsn. comprising same |
11/21/2000 | US6150557 Compounds |
11/21/2000 | US6150533 N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
11/21/2000 | US6150394 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
11/21/2000 | US6150388 Indole derivatives as 5-HT1 agonists |
11/21/2000 | US6150379 Compounds and compositions as anticoagulants |
11/21/2000 | US6150362 Administering 1,3,5-substituted triazine compounds to the patient suffering from angiogenic diseases |
11/21/2000 | US6150360 Administering to a patient suffering from human immunodeficiency virus infection a trisubstituted 1,3,5-triazine derivative |
11/21/2000 | CA2013048C Substituted aminopyrroles as stabilisers for chlorine-containing polymers |
11/16/2000 | WO2000068228A1 4-(3',4'-heterocyclyl benzoyl) pyrazoles as herbicidal agents |
11/16/2000 | WO2000068224A1 Substituted benzolactam compounds |
11/16/2000 | WO2000068213A1 Substituted bicyclic compounds |
11/16/2000 | WO2000068206A1 Heterocyclically substituted benzimidazoles, the production and application thereof |
11/16/2000 | WO2000068197A1 3a,4,5,9b-TETRAHYDRO-1H-BENZ[e]INDOL-2-YL AMINE-DERIVED NEUROPEPTIDE Y RECEPTORS LIGANDS USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS |
11/16/2000 | WO2000068195A2 Substituted pyrrolidines as cell adhesion inhibitors |
11/16/2000 | WO2000067900A1 Novel triazine-based detoxification agents and their use |
11/16/2000 | WO2000067847A2 Use of dopamine d3 receptor ligands for producing medicaments for treating kidney disorders |
11/16/2000 | WO2000067735A2 USE OF SELECTIVE ANTAGONISTS OF THE α1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION |
11/16/2000 | WO2000067734A2 Use of phthalazine derivatives |
11/16/2000 | WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
11/16/2000 | WO2000035887A3 Vitronectin receptor antagonist pharmaceuticals |
11/16/2000 | WO2000034437A3 Inhibitors of prenyl-protein transferase |
11/16/2000 | WO2000009103A3 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
11/16/2000 | DE19921567A1 Verwendung von Phthalazine-Derivaten Use of derivatives phthalazines |
11/16/2000 | CA2373293A1 4-(3',4'-heterocyclyl benzoyl) pyrazoles as herbicidal agents |
11/16/2000 | CA2373079A1 Substituted benzolactam compounds |
11/16/2000 | CA2373035A1 3a,4,5,9b-tetrahydro-1h-benz¬e|indol-2-yl amine-derived neuropeptide y receptors ligands useful in the treatment of obesity and other disorders |
11/16/2000 | CA2372704A1 Use of phthalazine derivatives |
11/16/2000 | CA2369442A1 Novel triazine-based detoxification agents and their use |
11/16/2000 | CA2366201A1 Use of selective antagonists of the .alpha.1b-adrenergic receptor for improvement of sexual dysfunction |
11/15/2000 | EP1052255A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics. |
11/15/2000 | EP1052254A1 Nitrogenous heterocyclic derivatives and medicine thereof |
11/15/2000 | EP1051415A1 Benzamide derivatives as vasopressin antagonists |
11/15/2000 | EP1051407A1 2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
11/15/2000 | EP1051397A1 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
11/15/2000 | EP1051374A1 The use of compressed carbon dioxide in chemical reactions |
11/15/2000 | EP1051176A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS |
11/15/2000 | EP1051144A1 Use of heterocyclic quaternary polyammonium polymers as protective agent for keratin fibres and cosmetic compositions |